Literature DB >> 993790

Determination of conjugated monoamine metabolites in brain tissue.

C G Swahn, F A Wiesel.   

Abstract

Levels of free and conjugated monoamine metabolites were analysed in brain tissue of rat and man. In the rat the conjugates were mainly of the sulfate ester type. The levels of conjugated dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) constituted 40--50% of the total amount of the metabolites. 4-Hydroxy-3-methoxy-phenylglycol (HMPG) and 5-hydroxy-3-indoleacetic acid (5-HIAA) were present as conjugates in 90 and 10% of the total levels. Chlorpromazine treatment resulted in an elevation of both the free and the conjugated forms of the dopamine metabolites and HMPG. In a human caudate nucleus obtained at autopsy both DOPAC and HMPG were present in the free form and as sulfate and glucuronide conjugates. The major dopamine metabolite found in this human brain was HVA. This metabolite and 5-HIAA occurred predominantly as free metabolites.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993790     DOI: 10.1007/bf01266304

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  15 in total

1.  Simultaneous mass fragmentographic determination of 3, 4-dihydroxyphenylacetic acid and 4 hydroxy-3-methoxyphenylacetic acid in brain tissue.

Authors:  F A Wiesel; C G Fri; G Sedvall
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

2.  Biogenic amines and their metabolites as substrates for phenol sulphotransferase (EC 2.8.2.1) of brain and liver.

Authors:  J K Meek; N H Neff
Journal:  J Neurochem       Date:  1973-07       Impact factor: 5.372

3.  Urinary excretion of 4-hydroxy-3-methoxyphenylglycol and 4-hydroxy-3-methoxyphenylethanol in man and rat.

Authors:  F Karoum; H Lefèvre; L B Bigelow; E Costa
Journal:  Clin Chim Acta       Date:  1973-01-10       Impact factor: 3.786

4.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

5.  Metabolism of catecholamines--identification and quantification of 3-methoxy-4-hydroxyphenylglycol glucuronide in human urine.

Authors:  H Shimizu; E H LaBrosse
Journal:  Biochem Pharmacol       Date:  1969-07       Impact factor: 5.858

6.  Mass fragmentographic determination of 4-hydroxy-3-methoxyphenylglycol (HMPG) in urine, cerebrospinal fluid, plasma and tissues using a deuterium-labelled internal standard.

Authors:  B Sjöquist; B Lindström; E Anggård
Journal:  J Chromatogr       Date:  1975-02-26

7.  Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.

Authors:  B Sandgárde; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

8.  Metabolism of 3-hydroxytyramine (dopamine) in human subjects.

Authors:  M Goodall; H Alton
Journal:  Biochem Pharmacol       Date:  1968-06       Impact factor: 5.858

9.  The presence of free and conjugated 3,4:dihydroxyphenylacetic acid (dopac) in urine and blood plasma.

Authors:  U von EULER; I FLODING; F LISHAJKO
Journal:  Acta Soc Med Ups       Date:  1959

10.  Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid.

Authors:  S Wilk; K L Davis; S B Thacker
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

View more
  16 in total

1.  Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.

Authors:  P Riederer; W Birkmayer; D Seemann; S Wuketich
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

2.  Central levels of noradrenaline, 3-methoxy-4-hydroxyphenylethyleneglycol and cyclic AMP in the rat after activation of locus coeruleus neurons: influence of single and repeated neuroleptic treatment.

Authors:  J P Adèr; J B Sebens; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 3.  Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary.

Authors:  L Peyrin
Journal:  J Neural Transm Gen Sect       Date:  1990

4.  Dopamine metabolites in human brain.

Authors:  S Wilk; M Stanley
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

5.  3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.

Authors:  M H Joseph; H F Baker; E C Johnstone; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

6.  Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

Authors:  A Zumstein; W Karduck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

7.  Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.

Authors:  S C Wheeler; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

8.  Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites.

Authors:  F A Wiesel; J Raaflaub; R Kettler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide.

Authors:  L Peyrin; J M Pequignot
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Conjugated HVA increase in rat urine after insulin-induced hypoglycemia: involvement of central dopaminergic structures but not of adrenal medulla.

Authors:  J M Cottet-Emard; L Peyrin
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.